Skip to content

A Community-Based Multi-Center Comparative Effectiveness Randomized Controlled Trial of Mobile Internet- and Social Media-based Intervention and Telemonitoring with Self-Management for Control of Blood Pressure in China

A Community-Based Multi-Center Comparative Effectiveness Randomized Controlled Trial of Mobile Internet- and Social Media-based Intervention and Telemonitoring with Self-Management for Control of Blood Pressure in China

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17013599
Enrollment
Unknown
Registered
2017-11-29
Start date
2016-11-01
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary hypertension

Interventions

Intervention group:home BP telemonitoring and social media with primary hypertension management
Control group:Routine management

Sponsors

Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) adult hypertensive patients registered with primary health institutions; (2) aged 30 years or older; (3) had at least two primary care outpatient encounters in 12 months prior to screening with BP >140/90 mmHg at the two most recent visits, and (4) smartphone owners and ability to use mobile application.

Exclusion criteria

Exclusion criteria: 1. Known secondary causes of hypertension like obstructive sleep apnea (OSA), aldosteronism, pheochromocytoma, Cushings syndrome, renal parenchymal disease, and renal artery stenosis; stage 4 or 5 kidney disease (eGFR <30 ml/min/1.73 m2 on the most recent determination of eGFR) or if the albumin-creatinine ratio is =700 mg/g creatinine in absence of urinary symptoms); (1) Had history of stroke, acute coronary syndrome, or coronary revascularization; (2) Left ventricular ejection fraction <30% or class III or IV New York Heart Association heart failure; (3) Unwillingness to be followed for a period of 12 months; (4) Dementia, mental illness or any condition that would limit ability to read, write, or communicate, or were considered to be inappropriate for the study by the physician.

Design outcomes

Primary

MeasureTime frame
the proportion of patients with controlled BP ;cardiovascular disease events;

Secondary

MeasureTime frame
change in other cardiovascular disease risk factors;hypertension medication adherence;

Countries

China

Contacts

Public ContactWu Zhaosu

Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease

wuzhaosu@263.net+86 13651108878

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026